1 Pazopanib Market Overview 1.1 Pazopanib Product Overview 1.2 Pazopanib Market Segment by Type 1.2.1 200mg Tables 1.2.2 400mg Tables 1.3 Global Pazopanib Market Size by Type 1.3.1 Global Pazopanib Market Size Overview by Type (2016-2027) 1.3.2 Global Pazopanib Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Pazopanib Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Pazopanib Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Pazopanib Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Pazopanib Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Pazopanib Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Pazopanib Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Pazopanib Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Pazopanib Sales Breakdown by Type (2016-2021) 1.4.2 Europe Pazopanib Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Pazopanib Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Pazopanib Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Pazopanib Sales Breakdown by Type (2016-2021) 2 Global Pazopanib Market Competition by Company 2.1 Global Top Players by Pazopanib Sales (2016-2021) 2.2 Global Top Players by Pazopanib Revenue (2016-2021) 2.3 Global Top Players Pazopanib Price (2016-2021) 2.4 Global Top Manufacturers Pazopanib Manufacturing Base Distribution, Sales Area, Product Type 2.5 Pazopanib Market Competitive Situation and Trends 2.5.1 Pazopanib Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Pazopanib Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pazopanib as of 2020) 2.7 Date of Key Manufacturers Enter into Pazopanib Market 2.8 Key Manufacturers Pazopanib Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Pazopanib Status and Outlook by Region 3.1 Global Pazopanib Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Pazopanib Historic Market Size by Region 3.2.1 Global Pazopanib Sales in Volume by Region (2016-2021) 3.2.2 Global Pazopanib Sales in Value by Region (2016-2021) 3.2.3 Global Pazopanib Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Pazopanib Forecasted Market Size by Region 3.3.1 Global Pazopanib Sales in Volume by Region (2022-2027) 3.3.2 Global Pazopanib Sales in Value by Region (2022-2027) 3.3.3 Global Pazopanib Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Pazopanib by Application 4.1 Pazopanib Market Segment by Application 4.1.1 Renal Cell Carcinoma 4.1.2 Soft Tissue Sarcoma 4.1.3 Other 4.2 Global Pazopanib Market Size by Application 4.2.1 Global Pazopanib Market Size Overview by Application (2016-2027) 4.2.2 Global Pazopanib Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Pazopanib Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Pazopanib Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Pazopanib Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Pazopanib Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Pazopanib Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Pazopanib Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Pazopanib Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Pazopanib Sales Breakdown by Application (2016-2021) 4.3.2 Europe Pazopanib Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Pazopanib Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Pazopanib Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Pazopanib Sales Breakdown by Application (2016-2021) 5 North America Pazopanib by Country 5.1 North America Pazopanib Historic Market Size by Country 5.1.1 North America Pazopanib Sales in Volume by Country (2016-2021) 5.1.2 North America Pazopanib Sales in Value by Country (2016-2021) 5.2 North America Pazopanib Forecasted Market Size by Country 5.2.1 North America Pazopanib Sales in Volume by Country (2022-2027) 5.2.2 North America Pazopanib Sales in Value by Country (2022-2027) 6 Europe Pazopanib by Country 6.1 Europe Pazopanib Historic Market Size by Country 6.1.1 Europe Pazopanib Sales in Volume by Country (2016-2021) 6.1.2 Europe Pazopanib Sales in Value by Country (2016-2021) 6.2 Europe Pazopanib Forecasted Market Size by Country 6.2.1 Europe Pazopanib Sales in Volume by Country (2022-2027) 6.2.2 Europe Pazopanib Sales in Value by Country (2022-2027) 7 Asia-Pacific Pazopanib by Region 7.1 Asia-Pacific Pazopanib Historic Market Size by Region 7.1.1 Asia-Pacific Pazopanib Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Pazopanib Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Pazopanib Forecasted Market Size by Region 7.2.1 Asia-Pacific Pazopanib Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Pazopanib Sales in Value by Region (2022-2027) 8 Latin America Pazopanib by Country 8.1 Latin America Pazopanib Historic Market Size by Country 8.1.1 Latin America Pazopanib Sales in Volume by Country (2016-2021) 8.1.2 Latin America Pazopanib Sales in Value by Country (2016-2021) 8.2 Latin America Pazopanib Forecasted Market Size by Country 8.2.1 Latin America Pazopanib Sales in Volume by Country (2022-2027) 8.2.2 Latin America Pazopanib Sales in Value by Country (2022-2027) 9 Middle East and Africa Pazopanib by Country 9.1 Middle East and Africa Pazopanib Historic Market Size by Country 9.1.1 Middle East and Africa Pazopanib Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Pazopanib Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Pazopanib Forecasted Market Size by Country 9.2.1 Middle East and Africa Pazopanib Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Pazopanib Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Pazopanib Business 10.1 Novartis 10.1.1 Novartis Corporation Information 10.1.2 Novartis Introduction and Business Overview 10.1.3 Novartis Pazopanib Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Novartis Pazopanib Products Offered 10.1.5 Novartis Recent Development 10.2 GlaxoSmithKline 10.2.1 GlaxoSmithKline Corporation Information 10.2.2 GlaxoSmithKline Introduction and Business Overview 10.2.3 GlaxoSmithKline Pazopanib Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Novartis Pazopanib Products Offered 10.2.5 GlaxoSmithKline Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Pazopanib Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Pazopanib Industrial Chain Analysis 11.4 Pazopanib Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Pazopanib Distributors 12.3 Pazopanib Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 200mg Tables Table 2. Major Company of 400mg Tables Table 3. Global Pazopanib Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Pazopanib Sales by Type (2016-2021) & (K Pcs) Table 5. Global Pazopanib Sales Market Share in Volume by Type (2016-2021) Table 6. Global Pazopanib Sales by Type (2016-2021) & (US& Million) Table 7. Global Pazopanib Market Share in Value by Type (2016-2021) Table 8. Global Pazopanib Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Pazopanib Sales by Type (2022-2027) & (K Pcs) Table 10. Global Pazopanib Sales Market Share in Volume by Type (2022-2027) Table 11. Global Pazopanib Sales by Type (2022-2027) & (US$ Million) Table 12. Global Pazopanib Sales Market Share in Value by Type (2022-2027) Table 13. Global Pazopanib Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Pazopanib Sales by Type (2016-2021) & (K Pcs) Table 15. North America Pazopanib Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Pazopanib Sales (K Pcs) by Type (2016-2021) Table 17. Europe Pazopanib Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Pazopanib Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Pazopanib Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Pazopanib Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Pazopanib Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Pazopanib Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Pazopanib Sales by Type (2016-2021) & (US$ Million) Table 24. Global Pazopanib Sales by Company (2016-2021) & (K Pcs) Table 25. Global Pazopanib Sales Share by Company (2016-2021) Table 26. Global Pazopanib Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Pazopanib Revenue Share by Company (2016-2021) Table 28. Global Market Pazopanib Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Pazopanib Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Pazopanib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pazopanib as of 2020 Table 32. Date of Key Manufacturers Enter into Pazopanib Market Table 33. Key Manufacturers Pazopanib Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Pazopanib Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Pazopanib Sales by Region (2016-2021) & (K Pcs) Table 37. Global Pazopanib Sales Market Share in Volume by Region (2016-2021) Table 38. Global Pazopanib Sales by Region (2016-2021) & (US$ Million) Table 39. Global Pazopanib Sales Market Share in Value by Region (2016-2021) Table 40. Global Pazopanib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Pazopanib Sales by Region (2022-2027) & (K Pcs) Table 42. Global Pazopanib Sales Market Share in Volume by Region (2022-2027) Table 43. Global Pazopanib Sales by Region (2022-2027) & (US$ Million) Table 44. Global Pazopanib Sales Market Share in Value by Region (2022-2027) Table 45. Global Pazopanib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Pazopanib Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Pazopanib Sales by Application (2016-2021) & (K Pcs) Table 48. Global Pazopanib Sales Market Share in Volume by Application (2016-2021) Table 49. Global Pazopanib Sales by Application (2016-2021) & (US$ Million) Table 50. Global Pazopanib Sales Market Share in Value by Application (2016-2021) Table 51. Global Pazopanib Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Pazopanib Sales by Application (2022-2027) & (K Pcs) Table 53. Global Pazopanib Sales Market Share in Volume by Application (2022-2027) Table 54. Global Pazopanib Sales by Application (2022-2027) & (US$ Million) Table 55. Global Pazopanib Sales Market Share in Value by Application (2022-2027) Table 56. Global Pazopanib Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Pazopanib Sales by Application (2016-2021) (K Pcs) Table 58. North America Pazopanib Sales by Application (2016-2021) & (US$ Million) Table 59. North America Pazopanib Sales Market Share in Value by Application in 2020 Table 60. Europe Pazopanib Sales by Application (2016-2021) (K Pcs) Table 61. Europe Pazopanib Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Pazopanib Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Pazopanib Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Pazopanib Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Pazopanib Sales Market Share in Value by Application in 2020 Table 66. Latin America Pazopanib Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Pazopanib Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Pazopanib Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Pazopanib Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Pazopanib Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Pazopanib Sales Market Share in Value by Application in 2020 Table 72. North America Pazopanib Sales by Country (2016-2021) & (K Pcs) Table 73. North America Pazopanib Sales Market Share in Volume by Country (2016-2021) Table 74. North America Pazopanib Sales by Country (2016-2021) & (US$ Million) Table 75. North America Pazopanib Sales Market Share in Value by Country (2016-2021) Table 76. North America Pazopanib Sales by Country (2022-2027) & (K Pcs) Table 77. North America Pazopanib Sales Market Share in Volume by Country (2022-2027) Table 78. North America Pazopanib Sales by Country (2022-2027) & (US$ Million) Table 79. North America Pazopanib Sales Market Share in Value by Country (2022-2027) Table 80. Europe Pazopanib Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Pazopanib Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Pazopanib Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Pazopanib Sales Market Share in Value by Country (2016-2021) Table 84. Europe Pazopanib Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Pazopanib Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Pazopanib Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Pazopanib Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Pazopanib Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Pazopanib Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Pazopanib Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Pazopanib Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Pazopanib Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Pazopanib Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Pazopanib Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Pazopanib Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Pazopanib Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Pazopanib Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Pazopanib Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Pazopanib Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Pazopanib Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Pazopanib Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Pazopanib Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Pazopanib Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Pazopanib Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Pazopanib Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Pazopanib Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Pazopanib Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Pazopanib Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Pazopanib Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Pazopanib Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Pazopanib Sales Market Share in Value by Country (2022-2027) Table 112. Novartis Corporation Information Table 113. Novartis Introduction and Business Overview Table 114. Novartis Pazopanib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. Novartis Pazopanib Product Table 116. Novartis Recent Development Table 117. GlaxoSmithKline Corporation Information Table 118. GlaxoSmithKline Introduction and Business Overview Table 119. GlaxoSmithKline Pazopanib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 120. GlaxoSmithKline Pazopanib Product Table 121. GlaxoSmithKline Recent Development Table 122. Key Raw Materials Lists Table 123. Raw Materials Key Suppliers Lists Table 124. Pazopanib Market Trends Table 125. Pazopanib Market Drivers Table 126. Pazopanib Market Challenges Table 127. Pazopanib Market Restraints Table 128. Pazopanib Distributors List Table 129. Pazopanib Downstream Customers Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Pazopanib Product Picture Figure 2. Global Pazopanib Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Pazopanib Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Pazopanib Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 200mg Tables Figure 6. Global 200mg Tables Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 400mg Tables Figure 8. Global 400mg Tables Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Pazopanib Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Pazopanib Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Pazopanib Sales Market Share in Value by Type (2016-2021) Figure 12. Global Pazopanib Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Pazopanib Sales Market Share in Value by Type (2022-2027) Figure 14. North America Pazopanib Sales Market Share in Volume by Type in 2020 Figure 15. North America Pazopanib Sales Market Share in Value by Type in 2020 Figure 16. Europe Pazopanib Sales Market Share in Volume by Type in 2020 Figure 17. Europe Pazopanib Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Pazopanib Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Pazopanib Sales Market Share in Value by Type in 2020 Figure 20. Latin America Pazopanib Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Pazopanib Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Pazopanib Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Pazopanib Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Pazopanib Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Pazopanib Revenue in 2020 Figure 26. Pazopanib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Renal Cell Carcinoma Figure 28. Global Renal Cell Carcinoma Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Soft Tissue Sarcoma Figure 30. Global Soft Tissue Sarcoma Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Other Figure 32. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Global Pazopanib Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Pazopanib Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Pazopanib Sales Market Share in Value by Application (2016-2021) Figure 36. Global Pazopanib Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Pazopanib Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Pazopanib Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Pazopanib Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Pazopanib Manufacturing Cost Structure Figure 42. Pazopanib Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Novartis GlaxoSmithKline